Collaboration - November 7, 2013
RaySearch enters agreement with Hitachi
RaySearch Laboratories AB has entered into a long-term distribution agreement with Hitachi Medical Corporation based in Tokyo, Japan. According to the agreement, Hitachi will be fully responsible for marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation on the Japanese market starting from April 1, 2014. “Hitachi Medical Corporation is a leading distributor […]
Uncategorized - November 7, 2013
Novo Nordisk supports diabetes researchers
Novo Nordisk and Oxford University team up to further enhance diabetes research and help the new generation of research leaders. The two have established an international fellowship program with the aim to support the development and career of young, exceptional research talent within diabetes. The new partnership will establish postdoctoral fellowship opportunities that will be […]
Collaboration - November 4, 2013
Otsuka named as Lundbeck’s partner in Japan on Nalmefene
Danish Lundbeck and Japanese Otsuka Pharmaceutical have announced that the companies’ existing alliance now also includes the development and commercialization of Nalmefene in Japan. Under the terms of the agreement, Lundbeck will receive an initial payment of EUR 50 million from Otsuka upon signing. Lundbeck will finance the development costs and has an option to […]
Uncategorized - September 10, 2013
Focus on pain relief at this year’s Swedish Pharmaceutical Congress
In November, representatives from the pharmaceutical industry, pharmacies and healthcare gather at the annual Swedish Pharmaceutical Congress. We had a chat with Anders Pesula at The Swedish Academy of Pharmaceutical Sciences to hear about this year’s theme. Anders Pesula, Swedish Academy of Pharmaceutical Sciences, what will be the theme of this year’s congress? “The focus […]
Regulatory compliance - September 2, 2013
Lundbeck appeals EU decision
The Danish pharmaceutical group Lundbeck is appealing against the 93.8 million euros fine by the European Commission announced in June. Lundbeck was fined for deals with rivals to block the supply of generic versions of its citalopra anti-depressant to the market, a decision that was announced earlier this summer. In a press release, Lundbeck states that […]
Acquisition - September 2, 2013
Meda acquires US respiratory company
Swedish Meda has signed an agreement to acquire the US development company Acton Pharmaceuticals, Inc. The agreement also includes the proprietary product Aerospan, an inhaler for the treatment of asthma that contains the active substance Flunisolide and approved by the FDA. The launch of Aerospan is planned to the beginning of 2014. According to Meda, the total […]
